Our most influential papers

Aktuelle High Impact-Publikationen

  • Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).
    Heidel* FH, De Stefano V, Zaiss M, Kisro J, Gückel E, Großer S, Zuurman MW, Manz K, Bryan K, Afsharinejad A, Griesshammer M, Kiladjian JJ
    Leukemia 2025, 39(7), 1692-701 * corresponding author
  • p53 reveals principles of chromatin remodeling and enhancer activation.
    Fischer M, Schwarz* R, Riege* K, Förste S, Schwab K, Wiechens E, van Bömmel A, Hoffmann S
    Nucleic Acids Res 2025, 53(11) * equal contribution
  • Aging and diet alter the protein ubiquitylation landscape in the mouse brain.
    Marino* A, Di Fraia* D, Panfilova D, Sahu AK, Minetti A, Omrani O, Cirri E, Ori A
    Nat Commun 2025, 16(1), 5266 * equal contribution
  • The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.
    Kühn MWM, Pemmaraju N, Heidel FH
    Leukemia 2025 (epub ahead of print)
  • Embryonic macrophages orchestrate niche cell homeostasis for the establishment of the definitive hematopoietic stem cell pool.
    Perçin** G, Riege K, Fröbel J, Metz J, Culemann S, Lesche M, Reinhardt S, Höfer T, Hoffmann S, Waskow** C
    Nat Commun 2025, 16(1), 4428 ** co-corresponding authors
  • Emerging roles of transfer RNA fragments in the CNS.
    Winek** K, Soreq** H
    Brain 2025 (epub ahead of print) ** co-corresponding authors